Connection
Paul Toren to Aryl Hydrocarbon Hydroxylases
This is a "connection" page, showing publications Paul Toren has written about Aryl Hydrocarbon Hydroxylases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.169 |
|
|
|
-
Ogilvie BW, Yerino P, Kazmi F, Buckley DB, Rostami-Hodjegan A, Paris BL, Toren P, Parkinson A. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. Drug Metab Dispos. 2011 Nov; 39(11):2020-33.
Score: 0.101
-
Ogilvie BW, Zhang D, Li W, Rodrigues AD, Gipson AE, Holsapple J, Toren P, Parkinson A. Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions. Drug Metab Dispos. 2006 Jan; 34(1):191-7.
Score: 0.068